The Role of Sleep in Protecting Spatial Memories From Age-Related Decline

November 10, 2026 updated by: Eitan Schechtman, University of California, Irvine

Healthy aging is characterized by impaired spatial memory compared to younger adults. These impairments not only negatively impact quality of life but are also an early marker for the onset of dementia, especially Alzheimer's Disease. While sleep plays an active role in spatial memory consolidation in young adults, the extent to which sleep contributes to this process in aged adults is yet to be determined. The objective of this developmental R21 project is to determine the impact of sleep on spatial memory in cognitively healthy, aged adults, and evaluate the potential for a sleep intervention targeting memory reactivation to improve performance in this population. The project will include a single experiment using an ecologically valid ambulatory virtual environment to test the effects of sleep on spatial memory performance in aged adults.

Aim 1 will determine whether post-learning sleep benefits spatial memory in aged adults, more so than a period of wakefulness. Spatial memory performance will be measured using well-established tasks in a virtual environment, before and after a 90-minute delay consisting of either an EEG-monitored nap or wakefulness. Changes in performance between these two conditions will be measured after the 90-minute delay and again one week later. The key hypothesis for this aim is that post-learning sleep will improve spatial memory recall more than an equivalent period of wakefulness, and that this improvement will correlate with sleep stages and EEG waveforms that are linked with memory consolidation.

Aim 2 will test whether targeted memory reactivation, a technique used to bias memory consolidation by obtrusively presenting sounds during sleep, can be used to enhance spatial memory in aged adults. To this end, task-related sounds will be presented to participants during a nap immediately after learning and during nocturnal sleep over the following week. Spatial memory performance will be compared between this group and a sleep group for which no sounds will be presented during sleep. The key hypotheses are that this manipulation will improve spatial memory performance, and that these behavioral effects will be mediated by memory-related EEG waveforms elicited by sounds presented during sleep.

By combining sleep, high-density electrophysiology, and a realistic testing environment, this project will determine the benefit of sleep on spatial memory in aged adults and test ways to leverage sleep to make consolidation more efficient. Results will inform our understanding of sleep-dependent consolidation in aged adults and pave the way for scalable, non-invasive treatments to improve day-to-day life and provide critical protections against dementia.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

126

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Eitan Schechtman-Drayman
  • Phone Number: 847-722-9220
  • Email: eitans@uci.edu

Study Contact Backup

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

60 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion:

  1. Age >=60.
  2. Montreal Cognitive Assessment score above 25.
  3. Good general health with no disease or conditions expected to interfere with the study.
  4. Fluent in English.
  5. Fully ambulatory without the use of a cane, walker, or wheelchair.
  6. Believe they will be able to fall asleep in a lab setting for an afternoon nap.

Exclusion:

  1. No history or current diagnosis of psychiatric disorders.
  2. No history or current neurological disease.
  3. No current sleep disorder, including sleep apnea and insomnia.
  4. No snoring during sleep.
  5. No uncorrected hearing, visual or motor impairment.
  6. No changes in medication usage over the past month and no plans to make such changes over the course of the study.

All inclusion/exclusion criteria, except for the Montreal Cognitive Assessment, will be based on self-report.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Wake group

Participants watch a feature-length film ("Stand By Me") in the study room for 90 minutes. They are instructed to remain awake and alert throughout. The experimenter monitors wakefulness from the control room via a baby monitor and a real-time EEG display. If EEG signs of non-rapid-eye-movement-sleep (NREM) Stage 1 or deeper sleep onset are observed, the participant is prompted to remain awake.

Active Comparator: Sleep group

Participants are given a 90-minute nap opportunity in a darkened sleep room (bed, clean linens, blanket) with low-volume white noise delivered via earphones. EEG (electroencephalography) with EOG (electrooculography) and EMG (electromyography) is recorded continuously. During NREM sleep, auditory cues that are unrelated to the virtual reality (VR) task are delivered. Once the experimenter confirms via real-time EEG that the participant is in NREM Stage 2 or Stage 3 sleep, non-task-associated auditory cues are delivered via a speaker at a volume calibrated individually during a Sound Volume Test before the nap - the lowest volume at which the participant can reliably detect the sound while awake. Following the nap, participants may shower or wash up in a private room with a sink.

This group will be allowed to sleep shortly after learning.

Experimental: Sleep+TargetedMemoryReactivation (TMR) Group

Participants follow the same nap protocol as the Sleep group, except that task-relevant sounds are presented during sleep. A minimum of 6 successful cue presentations during the nap is required for inclusion in TMR-specific analyses.

This group will be allowed to sleep shortly after learning.

The researchers will unobtrusively and repeatedly present a sound that was linked with a spatial task during sleep. This method was shown to improve memory in various tasks. The sounds will be presented both in the lab and at home. In both cases, the sounds will be presented during non-REM sleep stages 2 and 3. The sounds will only be presented to the Sleep+TMR group (N = 42).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Performance on spatial memory task - wayfinding task
Time Frame: Measured at baseline, approximately 2 hours later (after the delay, which includes wakefulness, sleep, or sleep with targeted memory reactivation), and after 1 week

Accuracy will be measured (percent of correct trials)

Measured at baseline, approximately 2 hours later (after the delay, which includes wakefulness, sleep, or sleep with targeted memory reactivation), and after 1 week
Performance on spatial memory task - pointing task
Time Frame: Measured at baseline, approximately 2 hours later (after the delay, which includes wakefulness, sleep, or sleep with targeted memory reactivation), and after 1 week

Angular error will be measured (averaged over trials)

Measured at baseline, approximately 2 hours later (after the delay, which includes wakefulness, sleep, or sleep with targeted memory reactivation), and after 1 week

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Performance on other memory tasks - paired-associates task
Time Frame: Measured at baseline, approximately 2 hours later (after the delay, which includes wakefulness, sleep, or sleep with targeted memory reactivation), and after 1 week

The researchers will use the paired-associates task to examine the effects of sleep on declarative memories. Percent correct pairs will be used.

Measured at baseline, approximately 2 hours later (after the delay, which includes wakefulness, sleep, or sleep with targeted memory reactivation), and after 1 week
Performance on other memory tasks - serial reaction time task
Time Frame: Measured at baseline, approximately 2 hours later (after the delay, which includes wakefulness, sleep, or sleep with targeted memory reactivation), and after 1 week

The researchers will use the serial reaction time task to examine the effects of sleep on non-declarative memories. The number of correct sequences will be used.

Measured at baseline, approximately 2 hours later (after the delay, which includes wakefulness, sleep, or sleep with targeted memory reactivation), and after 1 week

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Collaborators

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

November 5, 2026

Primary Completion (Estimated)

March 31, 2028

Study Completion (Estimated)

March 31, 2028

Study Registration Dates

First Submitted

October 29, 2026

First Submitted That Met QC Criteria

November 10, 2026

First Posted (Actual)

November 16, 2026

Study Record Updates

Last Update Posted (Actual)

November 16, 2026

Last Update Submitted That Met QC Criteria

November 10, 2026

Last Verified

November 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • 7502
  • R21AG101676 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

All datasets that can be shared will be deposited in OpenNeuro, which is an NIH-supported free and open platform for validating and sharing data. De-identified behavioral data, task programs and code, analysis code, experimental protocols, and any additional metadata will be stored and shared on the Open Science Framework. Additional code will be available on GitHub.

IPD Sharing Time Frame

Shared data generated from this project will be made available as soon as possible, and no later than the time of publication or the end of the funding period, whichever comes first. The duration of preservation and sharing of the data will be a minimum of 10 years after the end of the funding period.

IPD Sharing Access Criteria

There are no anticipated factors or limitations that will affect the access, distribution or reuse of the scientific data generated by the proposal.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.